Elizabeth Anderson

Elizabeth McKee Anderson currently works at BioMarin Pharmaceutical, Inc., as Independent Non-Executive Director from 2019, Insmed, Inc., as Independent Director from 2018, GSK Plc, as Independent Non-Executive Director from 2022, Bavarian Nordic GmbH, as Independent Director from 2017, Revolution Medicines, Inc., as Independent Director from 2015, Aro Biotherapeutics Co., as Independent Director from 2018, The Wistar Institute, as Trustee, Bryn Mawr Hospital Foundation, as Trustee, The Haverford School, as Trustee, and PureSight Advisory LLC, as Trustee & Principal.
Ms. Anderson also formerly worked at Centocor, Inc., as Director, Bavarian Nordic A, as Independent Director from 2017 to 2022, Huntsworth Ltd., as Independent Non-Executive Director from 2018 to 2019, Crucell Vaccines, Inc., as Director, Context Therapeutics LLC, as Director from 2018 to 2021, Bavarian Nordic A, as Independent Director, Johnson & Johnson, as VP & General Manager-Wyeth Lederle Vaccines from 1997 to 2009, Janssen Pharmaceuticals, Inc., as Vice President-Infectious Disease & Vaccines from 2003 to 2014, The American National Red Cross, as Vice President-Plasma Operations from 1989 to 1993, Rhone-Poulenc Rorer Pharmaceuticals, Inc., as Senior Vice President & General Manager from 1993 to 1997, Armour Pharmaceutical Co., as VP-Business Operations & GM-North America from 1993 to 1997, Centeon LLC, as Senior Vice President & GM-North America from 1993 to 1997, Wyeth Lederle Vaccines SA, as Vice President & General Manager from 1997 to 2002, and Wyeth Vaccines Research, as Vice President & General Manager.
Ms. Anderson received her undergraduate degree in 1979 from Rutgers State University of New Jersey and Masters Business Admin degree from Sellinger School of Business & Management.